Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2008
02/21/2008US20080045604 Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
02/21/2008US20080045603 Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity
02/21/2008US20080045602 Process for Preparation of 3-(2-Hydroxy-5Methylphenyl)-N, N-Disopropyl-3-Phenylpropylamine
02/21/2008US20080045600 Bicalutamide compositions
02/21/2008US20080045599 administering dalcetrapib with food
02/21/2008US20080045598 aromatase inhibitors such as N-methyl-N-[2-(4'-nitro benzyloxy)-4-nitrophenyl] methanesulfonamide, used for suppressing aromatase activity expression in breast cancer cells; anticarcinogenic agents
02/21/2008US20080045597 Dissolves quickly and completely in variety of foods and beverages without negatively impacting taste or texture; bone nutraceutical support
02/21/2008US20080045596 Ep2 Receptor Agonists
02/21/2008US20080045595 Method of treating cancer
02/21/2008US20080045594 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation
02/21/2008US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain
02/21/2008US20080045590 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
02/21/2008US20080045589 Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
02/21/2008US20080045588 Preparation and utility of substituted amphetamines
02/21/2008US20080045586 Oxydecahydronaphthalene modulators of hm74
02/21/2008US20080045585 Macrocyclic Compounds And Methods Of Making And Using The Same
02/21/2008US20080045584 Use of Docetaxel for Treating Hepatocellular Carcinoma
02/21/2008US20080045583 Stable levetiracetam compositions and methods
02/21/2008US20080045582 ENA-78 Gene Polymorphisms and Protein Concentrations as Diagnostic and Prognostic Tools
02/21/2008US20080045581 Ppar active compounds
02/21/2008US20080045580 Novel Isoxazole Compounds Having Ppar Agonist Activity
02/21/2008US20080045579 Oxazolidine derivatives as PR modulators
02/21/2008US20080045578 2-(4,4-Dimethyl-2-oxo-1,3-oxazolidin-3-yl)-4,5-dihydronaphtho[1,2-d] [1,3]thiazole-7-carbonitrile; progesterone receptor (PR); contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy
02/21/2008US20080045577 4-[2-(3,5,5-Trimethyl-2-oxoimidazolidin-1-yl)-1,3-thiazol-4-yl]benzonitrile; 1-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-3-methylimidazolidin-2-one; contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas
02/21/2008US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
02/21/2008US20080045575 Delivery of H2 Antagonists
02/21/2008US20080045574 thiazolidin-4-one derivatives used as antiprotozoa agents, or for the treatment of trypanosomiasis
02/21/2008US20080045573 Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
02/21/2008US20080045572 Pharmaceutical Composition Comprising Roflumilast or the N-Oxide of Roflumilast
02/21/2008US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/21/2008US20080045570 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation
02/21/2008US20080045568 Novel high affinity quinoline-based kinase ligands
02/21/2008US20080045567 Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes
02/21/2008US20080045566 6-substituted isoquinoline derivatives
02/21/2008US20080045565 Combinations Comprising Antimuscarinic Agents and Beta-Adrenergic Agonists
02/21/2008US20080045564 Quinine products, method of manufacture, method of use
02/21/2008US20080045563 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
02/21/2008US20080045562 Substituted Thieno[3,2-C]Pyridine-7-Carboxylic Acid Derivatives
02/21/2008US20080045561 protein kinase inhibitors such as 5,6-Dimethoxy-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-pyrrolo[3,2-b]pyridine, used for the treatment of cancer
02/21/2008US20080045560 Pyrrolidine and related derivatives useful as PR modulators
02/21/2008US20080045559 Tocopherol-modified therapeutic drug compounds
02/21/2008US20080045558 opiod and/or N-methylaspartic acid receptor modulators, used for the treatment and/or management of pain, neurodegenerative diseases, drug abuse and dependence, vision defects, or as muscle relaxants, antitussive and anxiolytic agents
02/21/2008US20080045557 Compounds and methods to inhibit or augment an inflammatory response
02/21/2008US20080045556 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy
02/21/2008US20080045555 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders
02/21/2008US20080045554 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders
02/21/2008US20080045553 Transdermal Administration of Phycotoxins
02/21/2008US20080045552 Methods of using selective chemotherapeutic agents for targeting tumor cells
02/21/2008US20080045551 Pharmaceutical combination comprising an adenosine a1 antagonist and a radiocontrast media
02/21/2008US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus
02/21/2008US20080045549 Adenosine a2b receptor antagonists
02/21/2008US20080045548 Pharmaceutical Compositions
02/21/2008US20080045547 Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use
02/21/2008US20080045546 Tetradydro-Naphthalene And Urea Derivatives
02/21/2008US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal
02/21/2008US20080045544 Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives
02/21/2008US20080045543 6-(2-Benzyl-piperazin-1-yl)-1H-indole, used as serotonin, norepinephrine or dopamine reuptake inhibitors; antidepressants; anxiolytic agents; monoamine reuptake inhibitors
02/21/2008US20080045542 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy
02/21/2008US20080045541 Dihydropyridinone Derivatives
02/21/2008US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
02/21/2008US20080045539 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease
02/21/2008US20080045538 Nitro and amino substituted topoisomerase agents
02/21/2008US20080045537 Chemical Compounds
02/21/2008US20080045536 Fused heterocyclic compounds useful as kinase modulators
02/21/2008US20080045535 Prokineticin 2 receptor antagonists
02/21/2008US20080045534 Derivatives of 1,3-diamino benzene as potassium channel modulators
02/21/2008US20080045533 Novel cyclohexyl sulphones
02/21/2008US20080045532 schizophrenia; 1-[4-(1-pyrrolidinylcarbonyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug
02/21/2008US20080045531 Anti-inflammatory medicaments
02/21/2008US20080045530 Organic Compounds and Their Uses
02/21/2008US20080045529 Use Of Thienopyrimidines
02/21/2008US20080045528 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
02/21/2008US20080045527 Immunomodulating Heterocyclic Compounds
02/21/2008US20080045526 Heteroaryl dihydroindolones as kinase inhibitors
02/21/2008US20080045525 Piperazinyl-Pyridine Analogues
02/21/2008US20080045524 Selective NPY (Y5) antagonists
02/21/2008US20080045523 Synthesis of Polyoxygenated Nitrogen Systems, Comprising Reactions Between Enamines of 1,3-Dioxan-5-Ones and Nitroolefins
02/21/2008US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
02/21/2008US20080045521 Phenylalanine derivatives
02/21/2008US20080045520 Substituted Pyrrolidine Derivative
02/21/2008US20080045518 3-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-4-methyl-1,3-oxazolidin-2-one; alternative progesterone receptor modulator; contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, hormone replacement therapy, eating disorder, synchronizing estrus
02/21/2008US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer
02/21/2008US20080045516 Viral Polymerase Inhibitors
02/21/2008US20080045515 To treat Alzheimer's disease; compounds with an additional fused ring containing an SO2 group; to suppress or attenuate the secretion of beta -amyloid; (4aSR,6RS,8aSR)-6-[(4-chlorophenyl)sulfonyl]-6-(2,5-difluorophenyl)-3-ethyloctahydro-1H-2,1,3-benzothiadiazine 2,2-dioxide; cyclization, alkylation
02/21/2008US20080045514 3-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereof
02/21/2008US20080045513 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
02/21/2008US20080045512 Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane
02/21/2008US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases
02/21/2008US20080045510 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
02/21/2008US20080045509 Substituted benzyl amine compounds
02/21/2008US20080045508 Substituted aminomethyl benzamide compounds
02/21/2008US20080045507 Substituted benzamide modulators of the histamine h3 receptor
02/21/2008US20080045506 Pyrrolidine Derivatives as Histamine Receptors Ligands
02/21/2008US20080045505 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
02/21/2008US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty
02/21/2008US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2008US20080045502 Processes for Preparing 3-Benzazepines
02/21/2008US20080045501 Pyrido(Hetero or carbo)cyclo)azepinylamine derivatives, e.g., 4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrido[3,4-d][2]benzazepin-2-yl]amino}-benzoic acid; 3-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrido[3,2-d][2]benzazepin-2-yl]-amino}benzoic acid; Aurora kinase inhibitors; anticancer agents
02/21/2008US20080045500 Nerve Regeneration Stimulator
02/21/2008US20080045499 Preferential Inhibition of Presenilin-1
1 ... 3370 3371 3372 3373 3374 3375 3376 3377 3378 3379 3380 3381 3382 3383 3384 3385 3386 3387 3388 3389 3390 ... 7860